Evidence map›Paper›PMID 37387156›Full record

ArticleBioinformatics (Oxford, England)2023

Transfer learning for drug-target interaction prediction.

Alperen Dalkıran, Ahmet Atakan, Ahmet S Rifaioğlu, Maria J Martin, Rengül Çetin Atalay, Aybar C Acar, Tunca Doğan, Volkan Atalay

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alperen DalkıranDepartment of Computer Engineering, Middle East Technical University, Ankara 06800, Turkey.
Ahmet AtakanDepartment of Computer Engineering, Middle East Technical University, Ankara 06800, Turkey.
Ahmet S RifaioğluDepartment of Computer Engineering, Iskenderun Technical University, Hatay 31200, Turkey.
Maria J MartinEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, Hinxton CB10 1SD, United Kingdom.
Rengül Çetin AtalayFaculty of Pulmonary and Critical Care Medicine, the University of Chicago, Chicago, IL, 60637, United States.
Aybar C AcarCancer Systems Biology Laboratory (Kansil), Middle East Technical University, Ankara 06800, Turkey.
Tunca DoğanEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, Hinxton CB10 1SD, United Kingdom.
Volkan AtalayDepartment of Computer Engineering, Middle East Technical University, Ankara 06800, Turkey.ORCID 0000-0001-7850-0601

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationUtilizing AI-driven approaches for drug-target interaction (DTI) prediction require large volumes of training data which are not available for the majority of target proteins. In this study, we investigate the use of deep transfer learning for the prediction of interactions between drug candidate compounds and understudied target proteins with scarce training data. The idea here is to first train a deep neural network classifier with a generalized source training dataset of large size and then to reuse this pre-trained neural network as an initial configuration for re-training/fine-tuning purposes with a small-sized specialized target training dataset. To explore this idea, we selected six protein families that have critical importance in biomedicine: kinases, G-protein-coupled receptors (GPCRs), ion channels, nuclear receptors, proteases, and transporters. In two independent experiments, the protein families of transporters and nuclear receptors were individually set as the target datasets, while the remaining five families were used as the source datasets. Several size-based target family training datasets were formed in a controlled manner to assess the benefit provided by the transfer learning approach.

resultsHere, we present a systematic evaluation of our approach by pre-training a feed-forward neural network with source training datasets and applying different modes of transfer learning from the pre-trained source network to a target dataset. The performance of deep transfer learning is evaluated and compared with that of training the same deep neural network from scratch. We found that when the training dataset contains fewer than 100 compounds, transfer learning outperforms the conventional strategy of training the system from scratch, suggesting that transfer learning is advantageous for predicting binders to under-studied targets. AVAILABILITY AND IMPLEMENTATION: The source code and datasets are available at https://github.com/cansyl/TransferLearning4DTI. Our web-based service containing the ready-to-use pre-trained models is accessible at https://tl4dti.kansil.org.

Indexed as

Neural Networks, ComputerPeptide HydrolasesMachine LearningSoftwarePeptide Hydrolases

Identifiers

PMID37387156
PMCPMC10311347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.